These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33799561)

  • 1. Rapid and High-Throughput Evaluation of Diverse Configurations of Engineered Lysins Using the VersaTile Technique.
    Duyvejonck L; Gerstmans H; Stock M; Grimon D; Lavigne R; Briers Y
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33799561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
    Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins.
    Gerstmans H; Grimon D; Gutiérrez D; Lood C; Rodríguez A; van Noort V; Lammertyn J; Lavigne R; Briers Y
    Sci Adv; 2020 Jun; 6(23):eaaz1136. PubMed ID: 32537492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.
    Binte Muhammad Jai HS; Dam LC; Tay LS; Koh JJW; Loo HL; Kline KA; Goh BC
    Front Microbiol; 2020; 11():574739. PubMed ID: 33324362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrogation of the contribution of (endo)lysin domains to tune their bacteriolytic efficiency provides a novel clue to design superior antibacterials.
    Gallego-Páramo C; Hernández-Ortiz N; García P; Menéndez M
    Int J Biol Macromol; 2022 Dec; 223(Pt A):1042-1053. PubMed ID: 36370862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered bacteriophage lysins as novel anti-infectives.
    Yang H; Yu J; Wei H
    Front Microbiol; 2014; 5():542. PubMed ID: 25360133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity.
    Yang H; Luo D; Etobayeva I; Li X; Gong Y; Wang S; Li Q; Xu P; Yin W; He J; Nelson DC; Wei H
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767724
    [No Abstract]   [Full Text] [Related]  

  • 8. Deep Antimicrobial Activity and Stability Analysis Inform Lysin Sequence-Function Mapping.
    Tresnak DT; Hackel BJ
    ACS Synth Biol; 2023 Jan; 12(1):249-264. PubMed ID: 36599162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Stabilization of a Prophage Lysin of Clostridium perfringens by Using Yeast Surface Display and Coevolutionary Models.
    Ritter SC; Hackel BJ
    Appl Environ Microbiol; 2019 May; 85(10):. PubMed ID: 30850429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Yang H; Wang M; Yu J; Wei H
    Front Microbiol; 2015; 6():1471. PubMed ID: 26733995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of Staphylococcal Cells by Modular Lysin Domains Linked via a Non-covalent Barnase-Barstar Interaction Bridge.
    Hjelm LC; Nilvebrant J; Nygren PÅ; Nilsson AS; Seijsing J
    Front Microbiol; 2019; 10():558. PubMed ID: 30967850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage endolysins and their applications.
    Ajuebor J; McAuliffe O; O'Mahony J; Ross RP; Hill C; Coffey A
    Sci Prog; 2016 Jun; 99(2):183-199. PubMed ID: 28742472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Substrate Specificity of NlpC/P60 Cell Wall Hydrolases Containing Bacterial SH3 Domains.
    Xu Q; Mengin-Lecreulx D; Liu XW; Patin D; Farr CL; Grant JC; Chiu HJ; Jaroszewski L; Knuth MW; Godzik A; Lesley SA; Elsliger MA; Deacon AM; Wilson IA
    mBio; 2015 Sep; 6(5):e02327-14. PubMed ID: 26374125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence.
    Zhang Y; Li R; Zou G; Guo Y; Wu R; Zhou Y; Chen H; Zhou R; Lavigne R; Bergen PJ; Li J; Li J
    Adv Sci (Weinh); 2024 Jun; ():e2404049. PubMed ID: 38899839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced engineering of third-generation lysins and formulation strategies for clinical applications.
    De Maesschalck V; Gutiérrez D; Paeshuyse J; Lavigne R; Briers Y
    Crit Rev Microbiol; 2020 Sep; 46(5):548-564. PubMed ID: 32886565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.